NDC 24208-040-41 - Xipere
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24208-040
- Requested NDC
- 24208-040-41
- Package NDCs from labels
- 24208-040-41, 24208-040-40, 24208-040-02, 24208-040-01
- Manufacturer
- Bausch & Lomb Incorporated | Alcami Carolinas Corporation
- Effective date
- 2025-10-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xipere - Bausch & Lomb Incorporated | Alcami Carolinas Corporation | Bausch & Lomb Incorporated | Alcami Carolinas Corporation | 2025-10-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24208-040-01 | Xipere | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-01 | Xipere | 1 in 1 TRAY | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-02 | Xipere | 0.9 mL in 1 VIAL | INJECTION, SUSPENSION | 0.9 | 7 | |
| 24208-040-40 | Xipere | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-40 | Xipere | 1 in 1 TRAY | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-41 | Xipere | 0.9 mL in 1 VIAL | INJECTION, SUSPENSION | 0.9 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 24208-040-40 | ML - Milliliter | 24208-040 | da6c08ed-251c-4030-bfaf-2d7e536d5c98 | 1 | 2023-01-09 |
| 24208-040-41 | ML - Milliliter | 24208-040 | 676b47a3-48f2-4885-932c-12f0b33f42bd | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | NuCare Pharmaceuticals,Inc. | bd465674-3527-1590-e053-2995a90a958d | 2026-02-19 | Adverse reactions | F446C597KA |
| RHODODIUM | ACTEA RACEMOSA, APIS MELL, CALC CARB, GRAPHITES, IODIUM, NATRUM MUR, PULSATILLA, RHODODENDRON | BM Private Limited | 3b3bcba2-6f9e-cd94-e063-6394a90a7701 | 2026-02-15 | Warnings | 451W47IQ8X |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | A-S Medication Solutions | 96f18791-480d-49f2-aac6-387321ae552c | 2026-02-14 | Adverse reactions | F446C597KA |
| Fuligo | CIMICIFUGA, DROSERA, FORMICA RUFA, FULIGO, INULA HEL., KALI MUR, LAPIS ALBUS, SILICEA | BM Private Limited | 3b27225f-4587-d915-e063-6294a90a7225 | 2026-02-12 | Warnings | 660YQ98I10 |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Amneal Pharmaceuticals LLC | c38dcd37-9840-4f71-a5c9-97380c8107f2 | 2026-02-12 | Warnings, Adverse reactions | F446C597KA |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Major Pharmaceuticals | 33ad1eb2-1f05-461c-b01d-82dee4231556 | 2026-02-11 | Warnings, Adverse reactions | 660YQ98I10 |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | A-S Medication Solutions | 51fedf94-d94e-42b7-8e9f-e0e9b6bbd055 | 2026-02-11 | Adverse reactions | F446C597KA |
| Walgreens ULTRA FINE MOISTURIZING SALINE MIST | NASAL MIST | WALGREEN COMPANY | 48fef521-1b1d-d0d5-e063-6394a90ac7b1 | 2026-02-10 | Warnings | 451W47IQ8X |
| Walgreens SALINE MIST | NASAL MIST | WALGREEN COMPANY | 44815675-cc1d-a582-e063-6394a90ae8f6 | 2026-02-10 | Warnings | 451W47IQ8X |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Sportpharm LLC | 4e0ddecf-7ea1-4f42-9924-53fe5a5657ff | 2026-02-10 | Warnings, Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | ASCLEMED USA INC. | 1c6a740e-bc0d-41f3-b576-7d4c3880be23 | 2026-02-10 | Warnings, Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | REMEDYREPACK INC. | c76d68dc-78e6-407c-ba9d-5d1c5d13509e | 2026-02-05 | Adverse reactions | F446C597KA |
| DPT-TOX | DROSERA, ECHINACEA, HYPERICUM, KALI MUR, MEZEREUM, SILICEA, THUJA | Nutrition Center Inc dba Nutri-West dba Micro-West | 5e39f4e6-939f-4b71-9cc5-6d4b8711ea32 | 2026-02-04 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | 5c2e888c-2f1e-4d5a-a456-20774ca83302 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Major Pharmaceuticals | 7d74652b-3513-4ebb-8b47-10b3603d04a7 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| 0.9 percentsaline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 487cb4fc-2e0b-020f-e063-6294a90a4526 | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e76aca-ca2b-3b95-e063-6394a90a875e | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9%saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e7b329-e4e5-6991-e063-6294a90ac817 | 2026-02-03 | Warnings | 451W47IQ8X |
| Calcium Chloride | CALCIUM CHLORIDE | Hospira, Inc. | c4c65e48-85f8-4dcf-6281-06e40959cc79 | 2026-02-02 | Warnings, Adverse reactions | M4I0D6VV5M |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Rising Pharma Holdings, Inc. | 947c11ca-ca0c-42df-8cc5-3db06458ca5b | 2026-02-01 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.